Corundum Systems Biology (CSB), a leading investment company dedicated to advancing life-changing systems biology solutions for human health and well-being, announced the opening of its first office in the U.S. Located at CIC Cambridge, One Broadway, in Cambridge, MA, the new office brings CSB even closer to innovators and researchers working in the microbiome and systems biology industries.
"Massachusetts, with its wealth of world-leading academic and research institutions, is the center of gravity for bioscience and medical innovation, making it an obvious choice for our U.S. headquarters," said Hidehiko Otake, CEO of Corundum Systems Biology. "With our growing presence in North America, we can tap into the vast amounts of research emerging from these world-class universities, source new opportunities to fund pioneering research and increase our collaborations with key partners."
Corundum Systems Biology addresses the fundamental challenges of healthy longevity through a 'systems' approach to funding scientific research. By looking at the interaction of the body's ecosystems to understand the underlying causes of disease, it supports the development of targeted interventions to delay or prevent the onset of disease. CSB provides access to funding, resources, and mentorship to help researchers and entrepreneurs bring solutions to commercialization.
To date, CSB has invested in three Boston-based biotech companies and continues to closely support their development and journey. The new office will provide invaluable opportunities for future collaboration and investment.
Comments powered by CComment